Hypertension: An autoimmune disease

Hypertension Research

Volumn 34, Issue 4, 2011, Pages 443-444

  Cohen Tervaert, Jan Willem ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; ANGIOTENSIN RECEPTOR; C REACTIVE PROTEIN; CD4 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 2; OXIDIZED LOW DENSITY LIPOPROTEIN; SODIUM; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; VITAMIN D;

ADAPTIVE IMMUNITY; ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PATHOGENESIS; REGULATORY T LYMPHOCYTE; SODIUM TRANSPORT; TH1 CELL; TH17 CELL; TH2 CELL; VITAMIN D DEFICIENCY;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASES; CELL MOVEMENT; CHEMOKINE CXCL10; HUMANS; HYPERTENSION; T-LYMPHOCYTE SUBSETS;

EID: 79953677208     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.15     Document Type: Note

References (19)

1. Stumpf C, Auer C, Yilmaz A, Lewczuk P, Klinghammer L, Schneider M, Daniel WG, Schmieder RE, Garlichs CD. Serum levels of the Th1 chemoattractant inter-feron-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension. Hypertens Res 2011; 34: 484-488.
2. Blake GJ, Rifai N, Buring JE, Ridker PM. Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003; 108: 2993-2999. (Pubitemid 37553568)
3. Svendsen UG. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice. Acta Pathol Microbiol Scand A 1976; 84: 523-528.
4. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460. (Pubitemid 47529329)
5. Marvar PJ, Thabet R, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010; 107: 263-270.
6. Herrera J, Ferrebuz A, Macgregor EG, Rodriguez-Iturbe B. Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis. J Am Soc Nephrol 2006; 17: S218-S225. (Pubitemid 44865252)
7. Ferro CJ, Edwards NC, Hutchison C, Cockwell P, Steeds RP, Savage CO, Townend JN, Harper L. Does immuno-suppressant medication lower blood pressure and arterial stiffness in patients with chronic kidney disease? An observational study. Hypertens Res 2011; 34: 113-119.
8. Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP, Multicenter AIDS Cohort Study. Association between highly active anti-retroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 2005; 19: 953-960. (Pubitemid 40834939)
9. Maggi E, Marchesi E, Ravetta V, Martignoni A, Finardi G, Bellomo G. Presence of autoantibodies against oxidatevely modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation. J Hypertens 1995; 13: 129-138.
10. Rouhl RP, Van Oostenbrugge RJ, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, Kroon AA, de Leeuw PW, Lodder J, Tervaert JW, Damoiseaux JG. Autoantibodies against oxidized low-density lipoprotein in cerebral small vessel disease. Stroke 2010; 41: 2687-2689.
11. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K, Fujita T. Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31-38. (Pubitemid 36842233)
12. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romag-nani P, Ghiadoni L, Serio M, Taddei S, Ferrannini E. High serum levels of CXC chemokine ligand 10 in untreated essential hypertension. J Hum Hypertens 2008; 22: 579-581.
13. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963-969.
14. Mallat Z, Taleb S, Ait-Oufella H, Tedgui A. The role of adaptive T cell immunity in atherosclerosis. J Lip Res 2009; 50: S364-S369.
15. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG. Interleukin 17 promotes angio-tensin II-induced hypertension and vascular dysfunction. Hypertension 2010; 55: 500-507.
16. Viel EC, Lemarié CA, Benkirane K, Paradis P, Schiffrin EL. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol 2010; 298: H938-H944.
17. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009; 4: e6635.
18. Burgaz A, Byberg L, Rautiainen S, Orsini N, Hakansson N, Arnlöv J, Sundström J, Lind L, Melhus H, Michaëls-son K, Wolk A. Confirmed hypertension and plasma 25(OH)D concentrations amongst elderly men. J Intern Med 2011; 269: 211-218.
19. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.